Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.

PubWeight™: 2.00‹?› | Rank: Top 2%

🔗 View Article (PMID 19662019)

Published in Hypertens Res on August 07, 2009

Authors

Daisuke Watanabe1, Akiyo Tanabe, Mitsuhide Naruse, Shunichi Morikawa, Taichi Ezaki, Kazue Takano

Author Affiliations

1: Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University, Tokyo, Japan.

Articles by these authors

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res (2009) 5.24

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res (2014) 4.83

Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol (2003) 2.90

An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension (2013) 2.72

Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2014) 2.72

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer (2014) 2.45

Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol (2003) 2.37

Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension (2006) 1.89

Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol (2004) 1.85

Ampulla cardiomyopathy after hypoglycemia in three young female patients with anorexia nervosa. Intern Med (2005) 1.80

Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients. J Clin Endocrinol Metab (2008) 1.71

Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. Endocr J (2011) 1.67

Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia. Growth Horm IGF Res (2006) 1.61

Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension (2003) 1.59

Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab (2010) 1.53

Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care (2004) 1.38

Increased expression of phosphorylated p70S6 kinase and Akt in papillary thyroid cancer tissues. Endocr J (2003) 1.23

The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab (2012) 1.23

Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus. J Immunol (2004) 1.10

Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry. J Clin Endocrinol Metab (2013) 1.09

Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy. J Clin Endocrinol Metab (2009) 1.06

Lack of ACTH and androgen receptor expression in a giant adrenal myelolipoma associated with 21-hydroxylase deficiency. Endocr Pathol (2008) 1.04

Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis. Nat Immunol (2005) 1.04

Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos. Mol Cell Biol (2005) 1.00

Ultrasonographic findings of papillary thyroid carcinoma with Hashimoto's thyroiditis. Intern Med (2007) 0.98

Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J Clin Endocrinol Metab (2004) 0.97

Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice. Int J Clin Exp Pathol (2013) 0.97

A case of double pylorus caused by recurrent gastric ulcers: a long-term endoscopic observation. Dig Dis Sci (2005) 0.96

Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. Endocr J (2009) 0.94

Etiology of hypercholesterolemia in patients with anorexia nervosa. Int J Eat Disord (2006) 0.93

Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia. Endocr J (2011) 0.93

Hypokalemia, diabetes mellitus, and hypercortisolemia are the major contributing factors to cardiac dysfunction in adrenal Cushing's syndrome. Endocr J (2009) 0.93

Toxic thyroid adenoma presenting as hypokalemic periodic paralysis. Endocr J (2007) 0.93

The prevalence of benign and malignant tumors in patients with acromegaly at a single institute. Endocr J (2008) 0.91

Characterization of sinusoidal endothelial cells of the liver and bone marrow using an intravital lectin injection method. J Mol Histol (2008) 0.90

Protective effect of vascular endothelial growth factor/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat. Lab Invest (2004) 0.90

Vitamin D deficiency in two young adults with biochemical findings resembling pseudohypoparathyroidism type I and type II. Endocr J (2010) 0.90

Increased thyroid blood flow in the hypoechoic lesions in patients with recurrent, painful Hashimoto's thyroiditis at the time of acute exacerbation. Endocr J (2008) 0.89

Regulation of nuclear retention of glucocorticoid receptor by nuclear Hsp90. Mol Cell Endocrinol (2004) 0.89

Systemic transmigration of allosensitizing donor dendritic cells to host secondary lymphoid organs after rat liver transplantation. Hepatology (2008) 0.89

Proliferating mesodermal cells in murine embryos exhibiting macrophage and lymphendothelial characteristics. BMC Dev Biol (2008) 0.89

Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats. Exp Eye Res (2012) 0.89

Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis. Endocr J (2009) 0.89

Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats. Hypertension (2002) 0.89

Transcatheter arterial embolization for the treatment of liver metastases in a patient with malignant pheochromocytoma. Endocr J (2006) 0.89

Invariant NKT cells induce plasmacytoid dendritic cell (DC) cross-talk with conventional DCs for efficient memory CD8+ T cell induction. J Immunol (2013) 0.88

New genetic causes of pheochromocytoma: current concepts and the clinical relevance. Keio J Med (2005) 0.88

Pediatric nonalcoholic steatohepatitis associated with hypopituitarism. J Gastroenterol (2005) 0.88

The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents. Life Sci (2007) 0.88

Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain. Acta Neuropathol (2006) 0.87

Iodide inhibits vascular endothelial growth factor-A expression in cultured human thyroid follicles: a microarray search for effects of thyrotropin and iodide on angiogenesis factors. Thyroid (2006) 0.87

Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome. Endocr J (2003) 0.87

Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy. Endocr J (2006) 0.86

Confirmatory testing in primary aldosteronism. J Clin Endocrinol Metab (2012) 0.86

P53 gene mutation in an atypical corticotroph adenoma with Cushing's disease. Clin Endocrinol (Oxf) (2008) 0.86

Intracellular binding of fukutin and alpha-dystroglycan: relation to glycosylation of alpha-dystroglycan. Neurosci Res (2006) 0.86

Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism. Clin Endocrinol (Oxf) (2014) 0.85

Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome. Endocr J (2008) 0.85

Symptomatic hypercalcemia due to painless thyroiditis after unilateral adrenalectomy in a patient with Cushing's syndrome. Intern Med (2008) 0.85

The influence of age on the GH-IGF1 axis in patients with acromegaly. Eur J Endocrinol (2008) 0.85

Diagnosis of thyroid follicular carcinoma by the vascular pattern and velocimetric parameters using high resolution pulsed and power Doppler ultrasonography. Endocr J (2005) 0.85

The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease. Thyroid (2007) 0.84

Alteration of angiogenic patterns on B16BL6 melanoma development promoted in Matrigel. Med Mol Morphol (2010) 0.84

Rapid differential diagnosis of Graves' disease and painless thyroiditis using total T3/T4 ratio, TSH, and total alkaline phosphatase activity. Endocr J (2005) 0.84

Characterization of the sugar chain expression of normal term human placental villi using lectin histochemistry combined with immunohistochemistry. Arch Histol Cytol (2009) 0.84

A novel GATA3 nonsense mutation in a newly diagnosed adult patient of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. Endocr Pract (2013) 0.84

Severe hyperreninemic hypertension associated with spontaneous renal cholesterol crystal embolization. Clin Exp Nephrol (2004) 0.84

The relationship between serum levels of estradiol and osteoprotegerin in patients with anorexia nervosa. Endocr J (2007) 0.83

Two young female patients with anorexia nervosa complicated by Mycobacterium tuberculosis infection. Intern Med (2004) 0.83

Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients. Neurodegener Dis (2009) 0.83

Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis. Mol Cancer (2014) 0.83

Combination chemotherapy with cyclophosphamide, vincristine, and dacarbazine in patients with malignant pheochromocytoma and paraganglioma. Horm Cancer (2013) 0.83

Prolongation of rat major histocompatibility complex-compatible cardiac allograft survival during pregnancy. J Heart Lung Transplant (2009) 0.83

Association of polymorphism at position 49 in exon 1 of the cytotoxic T-lymphocyte-associated factor 4 gene with Graves' disease refractory to medical treatment, but not with amiodarone-associated thyroid dysfunction. Thyroid (2009) 0.83

Suppression of iodide uptake and thyroid hormone synthesis with stimulation of the type I interferon system by double-stranded ribonucleic acid in cultured human thyroid follicles. Endocrinology (2007) 0.83

A novel missense mutation of AIRE gene in a patient with autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED), accompanied with progressive muscular atrophy: case report and review of the literature in Japan. Endocr J (2002) 0.83

Image in endocrinology. Pheochromocytoma with subclinical Cushing's syndrome caused by corticomedullary mixed tumor of the adrenal gland. J Clin Endocrinol Metab (2009) 0.83

Hyponatremia after transsphenoidal surgery for hypothalamo-pituitary tumors. Neuroendocrinology (2006) 0.83

Serum levels of IgG and IgG4 in Hashimoto thyroiditis. Endocrine (2013) 0.82

A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones. Endocrinology (2009) 0.82

Adrenocortical hyperplasia associated with ACTH-dependent Cushing's syndrome: comparison of the size of adrenal glands with clinical and endocrinological data. Endocr J (2004) 0.82

Serum concentrations of BNP and ANP in patients with thyrotoxicosis. Endocr J (2008) 0.82

Serum adiponectin levels in adult growth hormone deficiency and acromegaly. Growth Horm IGF Res (2004) 0.81